Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- RIGHT: Rhythm ID Going Head-to-Head Trial: Complete Statistical AnalysisIndependent statistical analysis of RIGHT: Rhythm ID Going Head-to-Head Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00148954).
- Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00523718).
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders: Complete Statistical AnalysisIndependent statistical analysis of Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RIPCOM1Independent statistical analysis of The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RISE AdultIndependent statistical analysis of RISE Adult Medication Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01779362).
- RISE-MIndependent statistical analysis of Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03634800).
- Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Rituximab and ABVD for Hodgkin’s Patients: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and ABVD for Hodgkin's Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504504).
- Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue: Complete Statistical AnalysisIndependent statistical analysis of Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01611259).
- RN-Led Palliative and Supportive Care Intervention: Complete Statistical AnalysisIndependent statistical analysis of RN-Led Palliative and Supportive Care Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04570709).
- Robotic Arm Assisted Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Robotic Arm Assisted Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02058069).
- Robotic Pedaling Therapy for Targeted Neural Plasticity: Complete Statistical AnalysisIndependent statistical analysis of Robotic Pedaling Therapy for Targeted Neural Plasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03300258).
- Robotic Single Port Donor Nephrectomy: Complete Statistical AnalysisIndependent statistical analysis of Robotic Single Port Donor Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01925677).
- ROCKETIndependent statistical analysis of A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Role of Everolimus in Highly Sensitized Patients: Complete Statistical AnalysisIndependent statistical analysis of Role of Everolimus in Highly Sensitized Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01911546).
- Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA): Complete Statistical AnalysisIndependent statistical analysis of Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01198509).
- Role of Pancreatic Triglyceride Content in Beta-cell Function: Complete Statistical AnalysisIndependent statistical analysis of Role of Pancreatic Triglyceride Content in Beta-cell Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00602953).
- Role of Soy Supplementation in Prostate Cancer Development: Complete Statistical AnalysisIndependent statistical analysis of Role of Soy Supplementation in Prostate Cancer Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00255125).
- Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: Complete Statistical AnalysisIndependent statistical analysis of Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of BMS-354825 in Patients With CML and Ph+ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030718).
- Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine: Complete Statistical AnalysisIndependent statistical analysis of Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROPIndependent statistical analysis of Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00634972).
- ROP1Independent statistical analysis of Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ROSEIndependent statistical analysis of A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Rotator Cuff Tears in Hemiplegic Shoulder: Complete Statistical AnalysisIndependent statistical analysis of Rotator Cuff Tears in Hemiplegic Shoulder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00998868).
- ROXI-VTE IIIndependent statistical analysis of A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: Complete Statistical AnalysisIndependent statistical analysis of rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02498067).
- RSV OA=ADJ-023Independent statistical analysis of A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant…
- RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- rTMS Bimodal Treatment For Tinnitus: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of rTMS Bimodal Treatment For Tinnitus: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01590264).
- rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: Complete Statistical AnalysisIndependent statistical analysis of rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial): primary endpoint results, effect…
- Rural Home Hospital: Proof of Concept: Complete Statistical AnalysisIndependent statistical analysis of Rural Home Hospital: Proof of Concept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04531280).
- Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF): Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02267278).
- Ruxolitinib for Adult T-Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib for Adult T-Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01712659).
- Ruxolitinib in Seborrheic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib in Seborrheic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05787860).
- RVD LiteIndependent statistical analysis of Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01782963).
- RVDDIndependent statistical analysis of Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00475176).